Article Text
Treatment
Review: low-molecular-weight heparin prevented recurrent VTE more than oral anticoagulants in patients with cancerCommentary
Statistics from Altmetric.com
Footnotes
Source of funding: no external funding.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
2008 RCN Publishing Company Limited and BMJ Publishing Group Ltd